Recent Findings Concerning PAMAM Dendrimer Conjugates with Cyclodextrins as Carriers of DNA and RNA

被引:37
作者
Arima, Hidetoshi [1 ]
Motoyama, Keiichi [1 ]
机构
[1] Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto 8620973, Japan
来源
SENSORS | 2009年 / 9卷 / 08期
基金
日本学术振兴会;
关键词
cyclodextrin; PAMAM dendrimer; carrier; DNA; siRNA; shRNA; NONVIRAL GENE DELIVERY; DRUG-DELIVERY; ALPHA-CYCLODEXTRINS; BETA-CYCLODEXTRIN; IN-VITRO; POLYAMIDOAMINE DENDRIMER; INDUCED HEMOLYSIS; THERAPY; POLYMERS; CELLS;
D O I
10.3390/s90806346
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
We have evaluated the potential use of various polyamidoamine (PAMAM) dendrimer [dendrimer, generation (G) 2-4] conjugates with cyclodextrins (CyDs) as novel DNA and RNA carriers. Among the various dendrimer conjugates with CyDs, the dendrimer (G3) conjugate with alpha-CyD having an average degree of substitution (DS) of 2.4 [alpha-CDE (G3, DS2)] displayed remarkable properties as DNA, shRNA and siRNA delivery carriers through the sensor function of alpha-CDEs toward nucleic acid drugs, cell surface and endosomal membranes. In an attempt to develop cell-specific gene transfer carriers, we prepared sugar-appended alpha-CDEs. Of the various sugar-appended.-CDEs prepared, galactose-or mannose-appended alpha-CDEs provided superior gene transfer activity to alpha-CDE in various cells, but not cell-specific gene delivery ability. However, lactose-appended alpha-CDE [Lac-alpha-CDE (G2)] was found to possess asialoglycoprotein receptor (AgpR)-mediated hepatocyte-selective gene transfer activity, both in vitro and in vivo. Most recently, we prepared folate-poly(ethylene glycol)-appended alpha-CDE [Fol-P alpha C (G3)] and revealed that Fol-P alpha C (G3) imparted folate receptor (FR)-mediated cancer cell-selective gene transfer activity. Consequently, alpha-CDEs bearing integrated, multifunctional molecules may possess the potential to be novel carriers for DNA, shRNA and siRNA.
引用
收藏
页码:6346 / 6361
页数:16
相关论文
共 87 条
[1]   Use of cyclodextrin and its derivatives for increased transformation efficiency of competent bacterial cells [J].
Aachmann, Finn Lillelund ;
Aune, Trond Erik Vee .
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2009, 83 (03) :589-596
[2]   GENE-THERAPY VECTORS AS DRUG-DELIVERY SYSTEMS [J].
AFIONE, SA ;
CONRAD, CK ;
FLOTTE, TR .
CLINICAL PHARMACOKINETICS, 1995, 28 (03) :181-189
[3]   Biocompatible micellar nanovectors achieve efficient gene transfer to vascular lesions without cytotoxicity and thrombus formation [J].
Akagi, D. ;
Oba, M. ;
Koyama, H. ;
Nishiyama, N. ;
Fukushima, S. ;
Miyata, T. ;
Nagawa, H. ;
Kataoka, K. .
GENE THERAPY, 2007, 14 (13) :1029-1038
[4]  
Akhtar S, 2006, GENE THER, V13, P739, DOI 10.1038/sj.gt.3302692
[5]   Polyfection as nonviral gene transfer method -: Design of novel nonviral vector using α-cyclodextrin [J].
Arima, H .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2004, 124 (07) :451-464
[6]   Enhancement of gene expression by polyamidoamine dendrimer conjugates with α-, β-, and γ-cyclodextrins [J].
Arima, H ;
Kihara, F ;
Hirayama, F ;
Uekama, K .
BIOCONJUGATE CHEMISTRY, 2001, 12 (04) :476-484
[7]  
ARIMA H, 2008, RECENT FINDINGS POLY
[8]   Enhancement of gene transfer activity mediated by mannosylated dendrimer/α-cyclodextrin conjugate (generation 3, G3) [J].
Arima, Hidetoshi ;
Chihara, Yuko ;
Arizono, Masayo ;
Yamashita, Shogo ;
Wada, Koki ;
Hirayama, Fumitoshi ;
Uekama, Kaneto .
JOURNAL OF CONTROLLED RELEASE, 2006, 116 (01) :64-74
[9]  
Arima H, 2005, RRD BIOCONJUGATE CHE, V2, P109
[10]   Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticles [J].
Bartlett, Derek W. ;
Davis, Mark E. .
BIOTECHNOLOGY AND BIOENGINEERING, 2008, 99 (04) :975-985